Late-Breaking Data Presented at the 2023 AAD Annual Meeting Demonstrates Improved Accuracy of DecisionDx®-SCC in Predicting Metastatic Risk Over Traditional Staging Systems in Independent, Multi-Center Cohort Study

Study data shows consistent independent risk stratification performance of DecisionDx-SCC in a novel cohort of patients with cutaneous squamous cell carcinoma and one or more risk factors
... | March 18, 2023

Related Keywords

United States ,American ,Castle Biosciences ,Instagram ,American Joint Committee On Cancer ,Linkedin ,Castle Biosciences Inc ,Twitter ,Nasdaq ,Orleans Ernestn Morial Convention Center Theater ,Securities Exchange ,Facebook ,Breaking Research ,New Orleans Ernest ,About Decisiondx ,Mypath Melanoma ,Securities Act ,Securities Exchange Act ,Annual Report ,American Joint Committee ,Nc Stock Exchange ,News ,Information ,Press Release ,Study ,Data ,Shows ,Consistent ,Independent ,Risk ,Estratification ,Performance ,F ,N ,Novel ,Cohort ,Patients ,Ith ,Cutaneous ,Squamous ,Fell ,Arcinoma ,End ,One ,Dr ,More ,Isk Cstl Us14843c1053 ,